Streetbeat News

Analyst Ratings

RWT

Credit Suisse analyst Douglas Harter maintains an Outperform rating on Redwood Trust (NYSE:RWT) and raises the price target from $8 to $9.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 12:38 pm

ADP

Barclays analyst Ramsey El-Assal has maintained an Overweight rating on Automatic Data Processing (NASDAQ:ADP) and raised the price target from $275 to $285.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 12:37 pm

AVTR

Credit Suisse analyst Dan Leonard has reiterated a Neutral rating on Avantor (NYSE:AVTR) and maintained a $24 price target.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 12:37 pm

PFSI

Credit Suisse analyst Douglas Harter maintains an Outperform rating on PennyMac Financial Servs (NYSE:PFSI) and raises the price target from $70 to $82.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 12:37 pm

CNHI

Credit Suisse analyst Jamie Cook has reiterated an Outperform rating on CNH Industrial (NYSE:CNHI) and maintained a $21 price target.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 12:36 pm

PMT

Credit Suisse analyst Douglas Harter maintains an Outperform rating on PennyMac Mortgage (NYSE:PMT) but lowers the price target from $15 to $14.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 12:35 pm

ACHC

Credit Suisse analyst A.J. Rice has reiterated an 'Outperform' rating on Acadia Healthcare Co (NASDAQ:ACHC) and maintained a $95 price target.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 12:34 pm

URGN

Goldman Sachs analyst Paul Choi maintains a Neutral rating on UroGen Pharma (NASDAQ:URGN) and raises the price target from $11 to $18.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 12:34 pm

MELI

Credit Suisse analyst Stephen Ju has maintained an Outperform rating on MercadoLibre (NASDAQ:MELI) and raised the price target from $1730 to $1760.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 12:34 pm

TER

Goldman Sachs analyst Toshiya Hari maintains a Neutral rating on Teradyne (NASDAQ:TER) and raises the price target from $97 to $115.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 12:33 pm